Description
alteraciones hormonales y función hepática
Ocrelizumab 300 mg/10 mL
Presentación :Empaque con 3 piezas
PRINCIPIO ACTIVO: METRONIDAZOL
KEYTRUDA® 100 mg es un medicamento de uso intravenoso que contiene Pembrolizumab
BUSCAPINA 10MG 24 GRAG CLOTRIMAZOL 2.00 G alteraciones hormonales y función hepáticaPRINCIPIO ACTIVO: BUTILHIOSCINA FORMA FARMACUTICA: 24 GRAGEAS PRESENTACIN: 1 CAJA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
